RD La Crosse Management, LLC

CI Financial provides unparalleled investment experiences through global wealth and asset management advisory services. With a heritage of growth, innovation and investment excellence since 1965, the company delivers an innovative selection of global wealth and asset management strategies, services, advice and technologies. CI Financial has developed world-class portfolio management talent with extensive capabilities in all aspects of wealth planning, managing over $550 billion in assets under management as of August 2025. The company is wholly owned by Mubadala Capital, the alternative asset management subsidiary of Mubadala Investment Company, a sovereign investor headquartered in Abu Dhabi. CI Financial operates through multiple business segments including CI Global Asset Management, CI Assante Wealth Management, CI Private Wealth, CI Direct Investing, and CI Investment Services Inc. The company serves approximately 1.3 million Canadians and maintains offices across Canada, the United States, and Asia-Pacific regions. CI Financial has been recognized as a Top Employer for 2026, reflecting its commitment to forward-thinking workplace policies and employee development. The company continues to modernize its asset management business, expand its wealth management platform, and globalize its operations to serve clients worldwide.

Midland Credit Management (MCM) is the market leader in portfolio purchasing and recovery in the United States. Established in 1953, MCM operates as a wholly-owned subsidiary of Encore Capital Group, providing debt recovery solutions across a broad range of assets. The company purchases portfolios of defaulted consumer receivables and manages them through consumer-centric practices that drive results. MCM partners with consumers as they repay their obligations and work toward financial recovery, having helped over 7 million people regain their financial independence. With over 4,000 employees worldwide and operations spanning the United States, Costa Rica, and India, MCM is headquartered in San Diego, California. In 2011, the company introduced the industry's first Consumer Bill of Rights, codifying its commitment to working with consumers through mutual engagement, understanding, collaboration, and respect. MCM helps consumers take control of their financial future by empowering them through flexible repayment options that fit their needs, ensuring every interaction is characterized by fairness and respect.

Old Harbor Solutions, LLC exists to deliver critical programmatic, technical, and administrative support to federal agencies that safeguard our nation's security and infrastructure. As an 8(a) Program certified, Alaska Native Corporation (ANC)-owned, Small Disadvantaged Business (SDB), we bring the unique capabilities and perspective of an ANC to government contracting - combining deep expertise in mission-critical domains with a commitment to excellence that spans the U.S. Coast Guard, Drug Enforcement Administration, Department of Energy, Department of Justice, and U.S. Navy. We specialize in Information Technology consultation, cybersecurity, program management, administrative services, and document management - services that are essential to modern government operations. As a subsidiary of Three Saints Bay, LLC, owned by Old Harbor Native Corporation, we leverage decades of experience and established contract growth to help federal customers achieve their objectives. Our teams apply industry best practices including PMBOK, CMMI, ITIL, and ISO to deliver results that matter - from base operations and acquisition support to law enforcement and intelligence services.

Wyndham Hotels & Resorts has grown into the world's largest hotel franchising company since its founding in 1981 by real estate developer Trammell Crow. What started as a single hotel in Dallas has evolved into a global hospitality powerhouse spanning 25 trusted brands across approximately 9,100 hotels in more than 95 countries. The company's mission to make hotel travel possible for all drives every decision, from franchise operations to guest experiences, with a focus on serving everyday travelers rather than just luxury seekers. As a publicly traded company (NYSE: WH) headquartered in Parsippany, New Jersey, Wyndham operates as a pure-play hotel franchisor with approximately 1,001-5,000 corporate team members supporting its vast network. The company's industry-leading Wyndham Rewards loyalty program boasts over 100 million members, offering simple and generous benefits that keep travelers coming back. Through strategic brand acquisitions and organic growth, Wyndham has built an unmatched portfolio ranging from economy to upscale segments, including iconic names like Ramada, Days Inn, Super 8, La Quinta, and Wyndham Grand, ensuring there's a Wyndham property for every traveler and every budget.

Crosslake Technologies conducts technical due diligence and risk assessment for private equity deals where software and infrastructure are material to valuation. Since 2010, the firm has evaluated over 6,000 technology investments for 500+ PE firms globally, focusing on threat surface mapping, technical debt quantification, and operational security posture before capital commits. Their proprietary TechIndicators® platform benchmarks target companies against $30 billion in transaction data - measuring everything from cloud architecture hygiene to identity management maturity across AWS, Azure, and GCP environments. The threat model here is investor exposure: acquirers inheriting unpatched systems, weak access controls, or compliance gaps that crater post-close valuations. Crosslake's practitioners - former senior executives averaging 20+ years in the field - assess Active Directory configurations, EDR/MDR deployment, and authentication frameworks like Office365 and G Suite to surface hidden liabilities. They also deploy interim CISOs into portfolio companies during integration windows when security leadership is absent or transitional. Beyond diligence, the firm provides strategic advisory on technology integration and value creation post-acquisition. This includes rationalization of overlapping security tooling, remediation roadmaps for critical vulnerabilities, and infrastructure consolidation across merged entities. The work is empirical and transactional - no vision decks, just concrete risk registers and benchmarked security postures that shape deal terms or kill transactions outright.

Merck Sharp & Dohme LLC operates as a research-intensive biopharmaceutical company with more than 130 years of operational history, developing medicines and vaccines for both human and animal health applications. Known as Merck & Co. in the United States and Canada, MSD maintains a global presence with what the company describes as one of the most diverse pharmaceutical pipelines in its history. The organization works across multiple technical domains including drug development, vaccine development, biopharmaceutical research, infectious disease research, and veterinary medicine, under CEO Robert M. Davis. The company's historical impact includes the development of streptomycin, an antibiotic credited with reducing tuberculosis deaths by nearly 50% by 1950. Current operations span human pharmaceuticals, vaccines, and a dedicated Animal Health division that addresses veterinary medicine, food safety, and agricultural protein supply challenges. MSD's technical focus areas include pharmaceutical pipeline development and public health initiatives, targeting what it characterizes as the world's most serious health concerns. For professionals evaluating biopharmaceutical organizations, MSD presents a large-scale research environment spanning infectious disease, drug discovery, and veterinary applications. The company operates under a stated philosophy that "medicine is for the people, not for the profits," though like all major pharmaceutical companies, it functions within commercial market structures. The scope of operations extends from basic research through clinical development to global distribution, requiring technical infrastructure to support complex supply chains, regulatory compliance systems, and data management across multiple therapeutic areas and geographic markets.